Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V8BU
|
|||
| Former ID |
DIB011467
|
|||
| Drug Name |
P-2202
|
|||
| Synonyms |
Metabolic disorder therapeutic, Piramal/Eli Lilly
Click to Show/Hide
|
|||
| Indication | Syndrome X [ICD-11: 5C53.4; ICD-10: E72.8] | Phase 2 | [1] | |
| Company |
Piramal Life Sciences Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01674348) A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.